<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <link rel="stylesheet" href="styles.css">
    <title>Home | Oncogenesis Patterns and Gaps</title>
    <link rel='icon' href='CB-logo.png' type='imax/x-icon'>
</head>
<body>
    <header>
        <h1 class='title'> 
        Understanding Genetic Patterns in Oncogenesis and Identifying Gaps in Treatment
        </h1>
        <nav>
            <ul>
                <li><a href='https://bettencourt-c.github.io/DS4200-final-project/'><b>Home</b></a></li>
                <li><a href='https://bettencourt-c.github.io/DS4200-FP-data/'>Data</a></li>
                <li><a href='https://bettencourt-c.github.io/DS4200-FP-results/'>Analysis & Results</a></li>
                <li><a href='https://bettencourt-c.github.io/DS4200-FP-summary/'>Summary</a></li>
                <li><a href='https://bettencourt-c.github.io/'>About the Author</a></li>
            </ul>
        </nav>
    </header>
    <main>
        <div class='content-container'>
            <h1 class='header1'> Introduction and Project Goals</h1>
            <p>According to the NIH, 611,720 people will die of cancer in the United States, with cancer prevalence continuing to rise [<a href='https://seer.cancer.gov/statfacts/html/common.html' target='_blank'>1</a>]. As a result, large amounts of funding go towards researching the mechanisms of different types of cancer, as well as for determining new treatments, with this value estimated to reach 307 billion USD by 2026 [<a href='https://www.nature.com/articles/d41586-023-02609-2' target='_blank'>2</a>]. Despite this funding, less prevalent cancers are marked as less profitable, and less research is done for these equally as harmful types of cancers.
                <br><br>
                The goal of this project is to provide a comprehensive review on the prevalence of cancer-causing genes on the human genome in comparison to current targeted therapies. Or simply, what is the relationship between mutations and cancer, and are current cancer drugs targeting the most common cancer-causing genes?
                <br><br>
                To achieve this, the patterns of cancer-associated mutations must first be investigated by investigating if there are specific chromosomes that are responsible for more cancer-associated mutations, and if certain locations on a chromosome are more likely to host cancer causing mutations. In addition, the distribution of types of mutations across somatic and germline DNA will be observed. Following this, the count of mutations for each cancer-associated gene will be calculated and compared to the count of responsive therapies the corresponding gene. Lastly, the distribution of responses of cancer treatments will be evaluated to determine if specific drug families are more susceptible to adverse reactions.
            </p>    
            <div class='references'>
                <ol>
                    <li>National Cancer Institute. (2024) Common Cancer Sites — Cancer Stat Facts. Retrieved November 16, 2024, from <a href='https://seer.cancer.gov/statfacts/html/common.html' target='_blank'>https://seer.cancer.gov/statfacts/html/common.html</a> </li>
                    <li>Sullivan R. (2023) The gross imbalances of cancer research must be addressed. Retrieved November 16, 2024, from <a href='https://www.nature.com/articles/d41586-023-02609-2' target='_blank'>https://www.nature.com/articles/d41586-023-02609-2</a> </li>
                    <li>Piovesan A. et al. (2019) On the length, weight and GC content of the human genome - PMC. Retrieved November 16, 2024, from <a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC6391780/' target='_blank'>https://pmc.ncbi.nlm.nih.gov/articles/PMC6391780/</a> </li>
                    <li>Barcelona Biomedical Genomics Lab. (2022) Cancer Genome Interpreter - Cancer Genome Interpreter Annotates The Biological And Clinical Relevance Of Tumor Alterations; doi: <a href='https://doi.org/10.1101/140475' target='_blank'>https://doi.org/10.1101/140475</a></li>
                    <li>Barcelona Biomedical Genomics Lab. (2018) Cancer Genome Interpreter - Identification of therapeutically actionable genomic alterations in tumors. Retrieved November 16, 2024, from <a href='https://www.cancergenomeinterpreter.org/mutations' target='_blank'>https://www.cancergenomeinterpreter.org/mutations</a> </li>
                    <li>HGVS recommendations for the description of sequence variants: 2016 update. Hum.Mutat. 25: 37: 564-569</li>
                    <li>Jefford C. & Irminger-Finger I. (2006) Mechanisms of chromosome instability in cancers - ScienceDirect. Retrieved November 16, 2024, from <a href='https://www.sciencedirect.com/science/article/abs/pii/S1040842806000412?fr=RR-9&ref=pdf_download&rr=8e38c2ae0ff48fcf' target='_blank'>https://www.sciencedirect.com/science/article/abs/pii/S1040842806000412?fr=RR-9&ref=pdf_download&rr=8e38c2ae0ff48fcf</a></li>
                    <li>National Cancer Institute. (2024) Leukemia — Cancer Stat Facts. Retrieved November 16, 2024, from <a href='https://seer.cancer.gov/statfacts/html/leuks.html' target='_blank'>https://seer.cancer.gov/statfacts/html/leuks.html</a></li>
                    <li>Ogza et al. (2023) Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG) | Leukemia. Retrieved November 16, 2024, from <a href='https://www.nature.com/articles/s41375-023-02068-8' target='_blank'>https://www.nature.com/articles/s41375-023-02068-8</a></li>
                    <li>McNulty M. & Crispino J. (2020) Acute Megakaryocytic Leukemia - PMC. Retrieved November 16, 2024, from <a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC6996441/' target='_blank'>https://pmc.ncbi.nlm.nih.gov/articles/PMC6996441/</a></li>
                    <li>Barnes et al. (2018) Carcinogens and DNA damage - PMC. Retrieved November 16, 2024, from <a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC6195640/' target='_blank'>https://pmc.ncbi.nlm.nih.gov/articles/PMC6195640/</a></li>
                    <li>Gorbunova V. & Seluanov A. (2017) DNA double strand break repair, aging and the chromatin connection - PMC. Retrieved November 16, 2024, from <a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC4887314/' target='_blank'>https://pmc.ncbi.nlm.nih.gov/articles/PMC4887314/</a></li>
                    <li>Lynch M. (2010) Evolution of the mutation rate - ScienceDirect. Retrieved November 16, 2024, from <a href='https://www.sciencedirect.com/science/article/abs/pii/S0168952510001034?via%3Dihub' target='_blank'>https://www.sciencedirect.com/science/article/abs/pii/S0168952510001034?via%3Dihub</a></li>
                    <li>Turner et al. (2007) The rates of de novo meiotic deletions and duplications causing several genomic disorders in the male germline - PMC. Retrieved November 16, 2024, from <a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC2669897/' target='_blank'>https://pmc.ncbi.nlm.nih.gov/articles/PMC2669897/</a></li>
                    <li>Zhang L. & Shay J. (2019) Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer - PMC. Retrieved November 16, 2024, from <a href='https://pmc.ncbi.nlm.nih.gov/articles/PMC5963831/' target='_blank'>https://pmc.ncbi.nlm.nih.gov/articles/PMC5963831/</a></li>
                    <li>Sinkala M. (2023) Mutational landscape of cancer-driver genes across human cancers | Scientific Reports. Retrieved November 16, 2024, from <a href='https://www.nature.com/articles/s41598-023-39608-2' target='_blank'>https://www.nature.com/articles/s41598-023-39608-2</a></li>
                    <li>NCI Dictionary of Cancer Terms. (2024) Definition of myelosuppression - NCI Dictionary of Cancer Terms - NCI. Retrieved November 16, 2024, from <a href='https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelosuppression' target='_blank'>https://www.cancer.gov/publications/dictionaries/cancer-terms/def/myelosuppression</a></li>
                    <li>National Heart, Lung, and Blood Institute. (2024) Anemia - Hemolytic Anemia | NHLBI, NIH. Retrieved November 16, 2024, from <a href='https://www.nhlbi.nih.gov/health/anemia/hemolytic-anemia' target='_blank'>https://www.nhlbi.nih.gov/health/anemia/hemolytic-anemia</a></li>
                    <li>Singh et al. (2023) Unconjugated Hyperbilirubinemia - StatPearls - NCBI Bookshelf. Retrieved November 16, 2024, from <a href='https://www.ncbi.nlm.nih.gov/books/NBK549796/' target='_blank'>https://www.ncbi.nlm.nih.gov/books/NBK549796/</a></li>
                    <li>Bostock M. (2023) Zoomable sunburst / D3 | Observable. Retrieved November 16, 2024, from <a href='https://observablehq.com/@d3/zoomable-sunburst' target='_blank'>https://observablehq.com/@d3/zoomable-sunburst</a> </li>
                    <li>Tan M. & Yu D. (2024) Molecular Mechanisms of ErbB2-Mediated Breast Cancer Chemoresistance - Madame Curie Bioscience Database - NCBI Bookshelf. Retrieved November 16, 2024, from <a href='https://www.ncbi.nlm.nih.gov/books/NBK6194/' target='_blank'>https://www.ncbi.nlm.nih.gov/books/NBK6194/</a></li>
                </ol>
            </div>
        </div>
        <div class='contact-info'>
            <h3>Contact Me</h3>
            <p>Preferred email: <a href='mailto:catarina.bettencourt.a@gmail.com'>catarina.bettencourt.a@gmail.com</a>    |    School email: <a href='mailto:bettencourt.c@northeastern.edu'>bettencourt.c@northeastern.edu</a><br>
            <a href='https://www.linkedin.com/in/catarina-bettencourt/' target='_blank'>LinkedIn</a> | <a href='https://bsky.app/profile/catarinabett.bsky.social' target='_blank'>Bluesky</a> | <a href='https://x.com/catarina_bett' target='_blank'>X</a></p>
        </div>
    </main>
</body>
</html>
